HIV/AIDS News

A study demonstrated that African women with HIV used ART for years and maintained high adherence, benefiting both themselves and their children.

After more than 40 years, scientists have yet to find a cure for HIV, a complex virus that can be suppressed with potent medications to undetectable levels in the body but not eliminated.

The FDA on Tuesday approved the first long-acting HIV treatment regimen for adolescents.

Adolescent girls and young women preferred the dapivirine ring over oral PrEP for HIV prevention by a two to one margin in a study conducted in three African countries, researchers reported Tuesday.

Broadly neutralizing monoclonal antibodies, or bNAbs, may be a viable treatment option for young children with HIV, according to study findings presented at the Conference on Retroviruses and Opportunistic Infections.

Maternal COVID-19 was associated with an increased risk for adverse birth outcomes among infants born to mothers in Botswana, including a two-fold risk for stillbirth, researchers found.

The first study to assess PrEP abandonment at retail pharmacies in the United States found that almost 9% of patients aged 16 years or older failed to pick up their prescriptions in 2019.

The AAP updated its guidance to recommend that all adolescents aged 15 years or older be screened for HIV at least once in a health care setting and that youth at an increased risk be screened at least once annually after that.

The FDA on Monday approved ViiV Healthcare’s cabotegravir as the first long-acting injectable for HIV PrEP.

The CDC on Wednesday recommended that all sexually active adults and adolescent patients be informed about HIV PrEP.